⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocksUnlock stocks

Biden COVID-19 task force says transition delay could be compromising U.S. virus response

Published 11/17/2020, 04:20 PM
Updated 11/17/2020, 09:45 PM
© Reuters. U.S. President-elect Joe Biden speaks about the U.S. economy after a briefing in Wilmington, Delaware

By Simon Lewis

WASHINGTON (Reuters) - Medical experts advising President-elect Joe Biden on the COVID-19 pandemic fear that the federal government's delay in recognizing Biden’s election victory could be compromising the U.S. response to the virus, the experts said on Tuesday.

Dr. Vivek Murthy, co-chair of Biden's COVID-19 task force, said the experts had not been able to speak to current administration officials dealing with the virus, even as the United States is hit by a surge in coronavirus cases and hospitalizations.

That could damage the incoming administration's ability to distribute a vaccine, for example, Murthy said.

"We need to talk to those individuals, we need to work together with them," Murthy said on a call with reporters arranged by Biden's transition team.

The General Services Administrator has not yet recognized Biden as the "apparent winner" of the Nov. 3 election, which is needed to release government funding for the transition. A spokeswoman said the administrator was following precedent and would make a decision once the winner is clear.

© Reuters. FILE PHOTO: 4th and final night of the 2020 Democratic National Convention, in Milwaukee

The experts were unable to access real-time data, including on hospital bed capacity and the amount of drugs and equipment in government stockpiles, said Murthy, a former U.S. surgeon general and one of 13 experts Biden last week appointed to advise him on COVID-19 during the transition.

"We can look at the publicly available data, but we don't have access to the full range of information that the federal government has to prepare for January 20," Murthy said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.